Characteristics | Details |
Study type |
|
| |
Publication year |
|
| |
| |
| |
Location |
|
| |
| |
| |
IPF diagnostic criteria |
|
| |
Design | Cohort study# |
| |
| |
RCT (n=16): all multicentre trials | |
Participant number | Cohort study# |
| |
| |
RCT (n=16): median (range) 94 (28–423)¶ | |
Duration | Cohort study#,+ |
| |
| |
RCT (n=16): all with a study duration of 1 year and <2 years |
IPF: idiopathic pulmonary fibrosis; ATS: American Thoracic Society; ERS: European Respiratory Society; JRS: Japanese Respiratory Society; ALAT: Latin American Thoracic Association; RCT: randomised controlled trial. #: not including Mura et al. [110]: a single-centre study with both prospective (n=70) and retrospective (n=68) cohorts, with a study duration ≥3 years; ¶: number of participants in the placebo arm only; +:: all studies had a study duration ≥1 year. Some studies provided mean or median follow-up duration which could not be incorporated into the table.